Taskinen, M-R <br/><br/>
Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes.  [electronic resource] 

 -  Diabetologia  Sep 2010 
 - 1846-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0428 
<br/><br/><label>Standard No.: </label>10.1007/s00125-010-1806-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Apolipoprotein A-I--metabolism<br/>Apolipoprotein A-II--blood<br/>Apolipoproteins--metabolism<br/>Apolipoproteins B--metabolism<br/>Cardiovascular Diseases--blood<br/>Cholesterol--blood<br/>Cholesterol, HDL--blood<br/>Diabetes Mellitus, Type 2--blood<br/>Female<br/>Fenofibrate--therapeutic use<br/>Humans<br/>Hypolipidemic Agents--therapeutic use<br/>Lipids--blood<br/>Male<br/>Middle Aged<br/>Risk Factors<br/>Triglycerides--blood